Doha Declaration

WTO compulsory licensing pact includes diagnostics

Despite the breakdown of negotiations at the Fifth World Trade Organization (WTO) Ministerial meeting in Cancun, Mexico, from 10-14 September 2003, a compulsory licensing agreement adopted by the WTO General Council prior to the Cancun meeting still stands1,2. The agreement will allow WTO members to import - under compulsory licences - drugs and in vitro diagnostics (IVDs) for various diseases that include but are not limited to HIV/AIDS, malaria and tuberculosis3-5.

The new agreement addresses paragraph six of the 2001 Declaration on the TRIPS Agreement and Public Health , which called...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Scrip

Finance Watch: Sarepta’s Debt Woes Grow With Elevidys Shipment Pause

 
• By 

Public Company Edition: Sarepta restructured after stopping shipments of its Elevidys for some patients to ease future debt pressures, but now it has stopped shipments to all patients. Also, Madrigal secured up to $500m in new debt, Cogent closed a $230m offering and other financings.

Avalyn Raises $100m Series D To Advance Inhaled Pulmonary Fibrosis Candidates

 
• By 

Looking to improve on the efficacy and safety of Roche’s Esbriet and BI’s Ofev, Avalyn has inhalable formulations of those drugs in Phase IIb and Phase I, respectively.

AstraZeneca Pledges Big Investment In US Manufacturing Amid Tariff Threats

 

The drugmaker plans to build a large manufacturing center in Virginia as the centerpiece of an effort to invest $50bn in the US by 2030.